GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Equity-to-Asset

Guanhao Biotech Co (SZSE:300238) Equity-to-Asset : 0.77 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Guanhao Biotech Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥534.9 Mil. Guanhao Biotech Co's Total Assets for the quarter that ended in Mar. 2024 was ¥692.4 Mil. Therefore, Guanhao Biotech Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.77.

The historical rank and industry rank for Guanhao Biotech Co's Equity-to-Asset or its related term are showing as below:

SZSE:300238' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.56   Med: 0.72   Max: 0.89
Current: 0.77

During the past 13 years, the highest Equity to Asset Ratio of Guanhao Biotech Co was 0.89. The lowest was 0.56. And the median was 0.72.

SZSE:300238's Equity-to-Asset is ranked better than
62.64% of 1558 companies
in the Biotechnology industry
Industry Median: 0.67 vs SZSE:300238: 0.77

Guanhao Biotech Co Equity-to-Asset Historical Data

The historical data trend for Guanhao Biotech Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Equity-to-Asset Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.62 0.71 0.72 0.77

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.76 0.78 0.77 0.77

Competitive Comparison of Guanhao Biotech Co's Equity-to-Asset

For the Biotechnology subindustry, Guanhao Biotech Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's Equity-to-Asset falls into.



Guanhao Biotech Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Guanhao Biotech Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=520.594/678.595
=0.77

Guanhao Biotech Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=534.904/692.368
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guanhao Biotech Co  (SZSE:300238) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Guanhao Biotech Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co (SZSE:300238) Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines